A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal
Pamela Schroeder(Johns Hopkins University), Paul W. Ladenson(Johns Hopkins Medicine), Gilbert H. Daniels(Harvard University), Markus Luster(Klinik und Poliklinik für Nuklearmedizin), Martin Schlumberger(Université Paris-Saclay), David S. Cooper(Johns Hopkins Medicine), Terry F. Davies(Icahn School of Medicine at Mount Sinai), Kathryn G. Schuff(Oregon Health & Science University), Christoph Reiners(Klinik und Poliklinik für Nuklearmedizin), Lewis E. Braverman(Brigham and Women's Hospital), Bryan R. Haugen(University of Colorado Cancer Center), Furio Pacini, Steven I. Sherman(Johns Hopkins University), Ernest L. Mazzaferri(The Ohio State University), E. Chester Ridgway(Boston University), Bruce D. Weintraub(University of Maryland, Baltimore), Mary H. Samuels(Oregon Health & Science University), Monica C. Skarulis(National Institutes of Health), Douglas S. Ross(Massachusetts General Hospital)
Cited by 198
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
|Thyroid|2016|2.8k
Subclinical Thyroid Disease
|JAMA|2004|1.8k
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|921